Medical News

RSS

New cryoablation technique eliminates ventricular tachycardia in 94% of patients

A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

8 Apr 2024

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

People with a small aortic annulus, a part of the heart's anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular self-expanding valve saw similar clinical outcomes and superior valve performance at one year compared with those who underwent TAVR with a balloon-expandable valve, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke out of the body, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Study shows reduced bleeding risk with ticagrelor monotherapy after percutaneous coronary intervention

People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin alongside the P2Y12 inhibitor ticagrelor one month after undergoing percutaneous coronary intervention (PCI) saw a significantly reduced risk of clinically meaningful bleeding with no increased risk of clotting-related adverse events at 12 months compared with patients who continued taking aspirin and ticagrelor for a full year, in a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels by more than half on average, compared with a placebo.

8 Apr 2024

Impella CP pump shows survival benefit in cardiogenic shock

Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Novel cholesterol removal strategy shows potential benefits post-heart attack

The first trial of a novel strategy for removing cholesterol from patients' arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology's Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.

8 Apr 2024

Study: Empagliflozin shows mixed results in heart attack patients

Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Study provides insights on lung transplantation in advanced age candidates

Data from the International Society for Heart and Lung Transplantation (ISHLT) indicates that the proportion of recipients aged 66 and above has risen to 19% by 2017.

8 Apr 2024

Interatrial shunt may offer differential benefits based on heart failure type

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure after a median of 22 months follow-up, in a study presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

MADs show comparable blood pressure reduction to CPAP in hypertensive patients with sleep apnea

People with hypertension and obstructive sleep apnea were no less likely to see their blood pressure drop over six months if they used a mandibular advancement device (MAD), which is inserted onto the teeth similar to a bite guard.

8 Apr 2024

App-based therapy offers significant improvement for men with bladder emptying disorders

Combining pelvic floor exercises with behavioral therapy could be more effective than current medical treatments at helping men with frequent urges to urinate, new research in men has found.

8 Apr 2024

Healthy eating, physical activity, and medication: Type 2 diabetes patients' willingness to engage varies

The willingness to engage in various management options for T2D among recently diagnosed patients.

8 Apr 2024

Could dried fruits be the key to reducing osteoarthritis risk?

Dry fruit intake may be causally associated with a reduced risk of osteoarthritis.

8 Apr 2024

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing any significant safety concerns, according to research presented at the American College of Cardiology's Annual Scientific Session.

8 Apr 2024

Expanding research and clinical options for children with cancer

In this interview, Dr. Church, the Molecular and Pediatric Pathologist at Boston Children's Hospital, talks to NewsMedical about their work in pediatric oncology, and the need to expand research and clinical options for children with cancer.

From Tecan 8 Apr 2024

Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company

When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn't disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database.

8 Apr 2024

Rising complaints of unauthorized Obamacare plan-switching and sign-ups trigger concern

Federal and state regulators aren't doing enough to stop the growing problem of rogue health insurance brokers making unauthorized policy switches for Affordable Care Act policyholders, say consumers.

8 Apr 2024

Gut-friendly psychobiotics could brighten moods and fight depression

Review uncovers that psychobiotics may offer supportive treatment for depression by restoring gut microbiome balance and positively influencing the microbiome-gut-brain axis, which is crucial for mental health and well-being.

8 Apr 2024

Ultra-processed foods linked to higher glaucoma risk, study warns

Study finds a significant relationship between the highest intake of ultra-processed foods, especially sweets, and an increased risk of developing glaucoma among Spanish university graduates, highlighting the importance of dietary quality for ocular health.

8 Apr 2024

Medical News

New cryoablation technique eliminates ventricular tachycardia in 94% of patients

SMART trial shows comparable outcomes of two common TAVR devices in small aortic annulus patients

Edetate disodium-based chelation ineffective for heart attack patients with diabetes

Study shows reduced bleeding risk with ticagrelor monotherapy after percutaneous coronary intervention

Lerodalcibep reduces LDL cholesterol by over 50% in high-risk patients

Impella CP pump shows survival benefit in cardiogenic shock

Novel cholesterol removal strategy shows potential benefits post-heart attack

Study: Empagliflozin shows mixed results in heart attack patients

Study provides insights on lung transplantation in advanced age candidates

Interatrial shunt may offer differential benefits based on heart failure type

MADs show comparable blood pressure reduction to CPAP in hypertensive patients with sleep apnea

App-based therapy offers significant improvement for men with bladder emptying disorders

Healthy eating, physical activity, and medication: Type 2 diabetes patients' willingness to engage varies

Could dried fruits be the key to reducing osteoarthritis risk?

Investigational drug plozasiran shows promise in reducing severe hypertriglyceridemia

Expanding research and clinical options for children with cancer

Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company

Rising complaints of unauthorized Obamacare plan-switching and sign-ups trigger concern

Gut-friendly psychobiotics could brighten moods and fight depression

Ultra-processed foods linked to higher glaucoma risk, study warns

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Latest News